We further demonstrated that miR-195 also targets genes involved in de novo lipogenesis, it inhibits cell proliferation, migration, and invasion by targeting FASN, HMGCR, ACACA and CYP27B1 thereby potentially opening new avenues for the treatment of breast cancer. The gene discussed is FASN; the disease is breast cancer.